Search

Author/Creator Spitznagel, Thomas M.

2. Subvisible (2–100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy. Issue 6 (1st April 2015)

Authors:
Narhi, Linda O.; Corvari, Vincent; Ripple, Dean C.; Afonina, Nataliya; Cecchini, Irene; Defelippis, Michael R.; Garidel, Patrick; Herre, Andrea; Koulov, Atanas V.; Lubiniecki, Tony; Mahler, Hanns‐Christian; Mangiagalli, Paolo; Nesta, Douglas; Perez‐Ramirez, Bernardo; Polozova, Alla; Rossi, Mara; ...
Journal:
Journal of pharmaceutical sciences
Issue:
Volume 104:Issue 6(2015:Jun.)
Page Start:
1899
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis. Issue 6 (November 2015)

Authors:
Corvari, Vincent; Narhi, Linda O.; Spitznagel, Thomas M.; Afonina, Nataliya; Cao, Shawn; Cash, Patricia; Cecchini, Irene; DeFelippis, Michael R.; Garidel, Patrick; Herre, Andrea; Koulov, Atanas V.; Lubiniecki, Tony; Mahler, Hanns-Christian; Mangiagalli, Paolo; Nesta, Douglas; Perez-Ramirez, Berna...
Journal:
Biologicals
Issue:
Volume 43:Issue 6(2015:Nov.)
Page Start:
457
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗